Brett Froeliger
Overview
Explore the profile of Brett Froeliger including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
82
Citations
1557
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jones S, Alberg A, Wallace K, Froeliger B, Carpenter M, Wolf B
Nicotine Tob Res
. 2024 Dec;
PMID: 39673390
Introduction: Genetic studies of smoking cessation have been limited by short-term follow-up or cross-sectional design. Within seven genes (CHRNA3, CHRNA5, CHRNB2, CHRNB4, DRD2, DBH and CYP2A6) influencing biological mechanisms relevant...
2.
Sahlem G, Dowdle L, Baker N, Sherman B, Gray K, McRae-Clark A, et al.
Biol Psychiatry Cogn Neurosci Neuroimaging
. 2024 Sep;
PMID: 39326740
Background: Functional magnetic resonance imaging studies examining cue reactivity in cannabis use disorder (CUD) either have had small sample sizes or have involved non-treatment-seeking participants. As a secondary analysis, we...
3.
Smith A, Azeem M, Odhiambo C, Wright P, Diktas H, Upton S, et al.
Sensors (Basel)
. 2024 Jul;
24(14).
PMID: 39065939
The characterization of human behavior in real-world contexts is critical for developing a comprehensive model of human health. Recent technological advancements have enabled wearables and sensors to passively and unobtrusively...
4.
Cofresi R, Upton S, Brown A, Piasecki T, Bartholow B, Froeliger B
Addict Neurosci
. 2024 Jun;
11.
PMID: 38938269
Low sensitivity (LS) to alcohol is a risk factor for alcohol use disorder (AUD). Compared to peers with high sensitivity (HS), LS individuals drink more, report more problems, and exhibit...
5.
Rolbiecki A, Froeliger B, Smith J, Ying J, Canfield S, Posley K, et al.
Palliat Support Care
. 2024 Mar;
22(4):811-817.
PMID: 38454804
Objectives: Managing cancer symptoms while patients receive systemic treatment remains a challenge in oncology. The use of complementary and alternative medicine (CAM) approaches like virtual reality (VR) and neurofeedback (NF)...
6.
Massey Z, Hammond D, Froeliger B
Prev Med Rep
. 2024 Jan;
37:102573.
PMID: 38222305
Background: Cannabis legalization provides an opportunity to communicate with consumers through mandated health warnings on cannabis packaging. However, research on cannabis health warnings is a nascent field. Therefore, a review...
7.
Garland E, Nakamura Y, Bryan C, Hanley A, Parisi A, Froeliger B, et al.
Am J Psychiatry
. 2024 Jan;
181(2):125-134.
PMID: 38196335
Objective: This randomized clinical trial evaluated the efficacy of Mindfulness-Oriented Recovery Enhancement (MORE) among past and present U.S. military personnel with prescriptions for long-term opioid therapy for chronic pain. Methods:...
8.
Sahlem G, Dowdle L, Baker N, Sherman B, Gray K, McRae-Clark A, et al.
medRxiv
. 2023 Nov;
PMID: 38014250
Introduction: Functional magnetic resonance imaging (fMRI) studies examining cue-reactivity in cannabis use disorder (CUD) to date have either involved non-treatment seeking participants or been small. We addressed this gap by...
9.
Upton S, Brown A, Ithman M, Newman-Norlund R, Sahlem G, Prisciandaro J, et al.
Biol Psychiatry Cogn Neurosci Neuroimaging
. 2023 Aug;
8(11):1156-1165.
PMID: 37567363
Background: Nicotine dependence is associated with dysregulated hyperdirect pathway (HDP)-mediated inhibitory control (IC). However, there are currently no evidence-based treatments that have been shown to target the HDP to improve...
10.
Rolbiecki A, Govindarajan A, Froeliger B
Support Care Cancer
. 2023 Jul;
31(8):493.
PMID: 37493785
Millions of people are diagnosed with cancer each year in the USA and are living on systemic therapies designed to prolong their life. While these therapies are intended to treat...